These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Emerging targets for the treatment of dyslipidemia. Tavridou A; Ragia G; Manolopoulos VG Curr Med Chem; 2011; 18(6):909-22. PubMed ID: 21182475 [TBL] [Abstract][Full Text] [Related]
3. Optimal management of combined dyslipidemia: what have we behind statins monotherapy? Tenenbaum A; Fisman EZ; Motro M; Adler Y Adv Cardiol; 2008; 45():127-153. PubMed ID: 18230960 [TBL] [Abstract][Full Text] [Related]
4. An overview of the new frontiers in the treatment of atherogenic dyslipidemias. Rached FH; Chapman MJ; Kontush A Clin Pharmacol Ther; 2014 Jul; 96(1):57-63. PubMed ID: 24727469 [TBL] [Abstract][Full Text] [Related]
5. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update. Reiner Z Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901 [TBL] [Abstract][Full Text] [Related]
6. Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy. Gaudet D; Drouin-Chartier JP; Couture P Can J Cardiol; 2017 Jul; 33(7):872-882. PubMed ID: 28365054 [TBL] [Abstract][Full Text] [Related]
7. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
8. Novel agents to manage dyslipidemias and impact atherosclerosis. Nachimuthu S; Raggi P Cardiovasc Hematol Disord Drug Targets; 2006 Sep; 6(3):209-17. PubMed ID: 17017903 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol. Xiao C; Dash S; Morgantini C; Hegele RA; Lewis GF Diabetes; 2016 Jul; 65(7):1767-78. PubMed ID: 27329952 [TBL] [Abstract][Full Text] [Related]
10. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk. Shapiro MD; Fazio S Circ Res; 2016 Feb; 118(4):732-49. PubMed ID: 26892970 [TBL] [Abstract][Full Text] [Related]
11. Lipid pharmacotherapy for treatment of atherosclerosis. Nicholls SJ; Pisaniello AD; Kataoka Y; Puri R Expert Opin Pharmacother; 2014 Jun; 15(8):1119-25. PubMed ID: 24702590 [TBL] [Abstract][Full Text] [Related]